this post was submitted on 09 Oct 2023
32 points (100.0% liked)

News

51 readers
1 users here now

Breaking news and current events worldwide.

founded 2 years ago
32
California governor vetoes bill that would have set a $35 cap for insulin (www.theguardian.com)
submitted 2 years ago by athos77@kbin.social to c/news@kbin.social
19 comments fedilink hide all child comments
 

Bill denial for the prescription drug price cap called ‘a major setback’ for diabetics in the state

you are viewing a single comment's thread
view the rest of the comments
[–] IHeartBadCode@kbin.social 21 points 2 years ago (1 children)

Just an FYI. The CalRx insulin is being produced by Civica Rx. They will be producing three insulins for the program. Glargie, Lispro, and Aspart. These are generic biologics that are interchangeable with Lantus (long-acting), Humalog (fact-acting), and Novolog (instant). Additionally, for the products where this makes sense, products will be available in vial and autoinjector formats. The $30 price is that of the vials and $55 for a box of five autoinjectors.

So main take aways should be CalRx will be producing analogs and will be providing a wide band of types for different needs.

[–] squiblet@kbin.social 1 points 2 years ago

Humalog (lispro) is approximately the same as Novolog (aspart). There are rapid actings, they are Fiasp and Lyumjev.